SLC5A2 and breast cancer: In agreement with a previous study (Komatsu et al., 2020), a comparative analysis of tumor and normal breast tissues acquired intraoperatively from 25 female patients with breast cancer revealed elevated mRNA and protein levels of SGLT-2 in breast cancer tissues compared with normal breast tissues.